Dupilumab Use Is Associated With Protection From Coronavirus Disease 2019 Mortality: A Retrospective Analysis.

Donlan, Alexandra N; Mallawaarachchi, Indika; Sasson, Jennifer M; Preissner, Robert; Loomba, Johanna J; Petri, William A

Donlan, Alexandra N; Mallawaarachchi, Indika; Sasson, Jennifer M; Preissner, Robert; Loomba, Johanna J; Petri, William A.

Afiliação

Donlan AN; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Mallawaarachchi I; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Sasson JM; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Preissner R; Science-IT and Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Loomba JJ; Integrated Translational Health Research Institute of Virginia (iTHRIV), Charlottesville, Virginia, USA.
Petri WA; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Clin Infect Dis ; 76(1): 148-151, 2023 01 06.

Article em En | MEDLINE | ID: mdl-36104868

Assuntos

COVID-19; Animais; Camundongos; Humanos; Estudos Retrospectivos; Anticorpos Monoclonais Humanizados/uso terapêutico; Anticorpos Monoclonais

Palavras-chave

COVID-19; dupilumab; infectious disease; type 2 immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google